颈部影像学报告和数据系统(NI-RADS)诊断头颈部鳞状细胞癌复发的性能:系统综述和荟萃分析。

IF 3.1 3区 医学 Q2 CLINICAL NEUROLOGY American Journal of Neuroradiology Pub Date : 2023-10-01 Epub Date: 2023-09-14 DOI:10.3174/ajnr.A7992
Akira Baba, Ryo Kurokawa, Mariko Kurokawa, Takafumi Yanagisawa, Ashok Srinivasan
{"title":"颈部影像学报告和数据系统(NI-RADS)诊断头颈部鳞状细胞癌复发的性能:系统综述和荟萃分析。","authors":"Akira Baba, Ryo Kurokawa, Mariko Kurokawa, Takafumi Yanagisawa, Ashok Srinivasan","doi":"10.3174/ajnr.A7992","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Neck Imaging Reporting and Data System (NI-RADS) is a reporting template used in head and neck cancer posttreatment follow-up imaging.</p><p><strong>Purpose: </strong>Our aim was to evaluate the pooled detection rates of the recurrence of head and neck squamous cell carcinoma based on each NI-RADS category and to compare the diagnostic accuracy between NI-RADS 2 and 3 cutoffs.</p><p><strong>Data sources: </strong>The MEDLINE, Scopus, and EMBASE databases were searched.</p><p><strong>Study selection: </strong>This systematic review identified 7 studies with a total of 694 patients (1233 lesions) that were eligible for the meta-analysis.</p><p><strong>Data analysis: </strong>The meta-analysis of pooled recurrence detection rate estimates for each NI-RADS category and the diagnostic accuracy of recurrence with NI-RADS 3 or 2 as the cutoff was performed.</p><p><strong>Data synthesis: </strong>The estimated recurrence rates in each category for primary lesions were 74.4% for NI-RADS 3, 29.0% for NI-RADS 2, and 4.2% for NI-RADS 1. The estimated recurrence rates in each category for cervical lymph nodes were 73.3% for NI-RADS 3, 14.3% for NI-RADS 2, and 3.5% for NI-RADS 1. The area under the curve of the summary receiver operating characteristic for recurrence detection with NI-RADS 3 as the cutoff was 0.887 and 0.983, respectively, higher than 0.869 and 0.919 for the primary sites and cervical lymph nodes, respectively, with NI-RADS 2 as the cutoff.</p><p><strong>Limitations: </strong>Given the heterogeneity of the data of the studies, the conclusions should be interpreted with caution.</p><p><strong>Conclusions: </strong>This meta-analysis revealed estimated recurrence rates for each NI-RADS category for primary lesions and cervical lymph nodes and showed that NI-RADS 3 has a high diagnostic performance for detecting recurrence.</p>","PeriodicalId":7875,"journal":{"name":"American Journal of Neuroradiology","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549942/pdf/","citationCount":"0","resultStr":"{\"title\":\"Performance of Neck Imaging Reporting and Data System (NI-RADS) for Diagnosis of Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.\",\"authors\":\"Akira Baba, Ryo Kurokawa, Mariko Kurokawa, Takafumi Yanagisawa, Ashok Srinivasan\",\"doi\":\"10.3174/ajnr.A7992\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The Neck Imaging Reporting and Data System (NI-RADS) is a reporting template used in head and neck cancer posttreatment follow-up imaging.</p><p><strong>Purpose: </strong>Our aim was to evaluate the pooled detection rates of the recurrence of head and neck squamous cell carcinoma based on each NI-RADS category and to compare the diagnostic accuracy between NI-RADS 2 and 3 cutoffs.</p><p><strong>Data sources: </strong>The MEDLINE, Scopus, and EMBASE databases were searched.</p><p><strong>Study selection: </strong>This systematic review identified 7 studies with a total of 694 patients (1233 lesions) that were eligible for the meta-analysis.</p><p><strong>Data analysis: </strong>The meta-analysis of pooled recurrence detection rate estimates for each NI-RADS category and the diagnostic accuracy of recurrence with NI-RADS 3 or 2 as the cutoff was performed.</p><p><strong>Data synthesis: </strong>The estimated recurrence rates in each category for primary lesions were 74.4% for NI-RADS 3, 29.0% for NI-RADS 2, and 4.2% for NI-RADS 1. The estimated recurrence rates in each category for cervical lymph nodes were 73.3% for NI-RADS 3, 14.3% for NI-RADS 2, and 3.5% for NI-RADS 1. The area under the curve of the summary receiver operating characteristic for recurrence detection with NI-RADS 3 as the cutoff was 0.887 and 0.983, respectively, higher than 0.869 and 0.919 for the primary sites and cervical lymph nodes, respectively, with NI-RADS 2 as the cutoff.</p><p><strong>Limitations: </strong>Given the heterogeneity of the data of the studies, the conclusions should be interpreted with caution.</p><p><strong>Conclusions: </strong>This meta-analysis revealed estimated recurrence rates for each NI-RADS category for primary lesions and cervical lymph nodes and showed that NI-RADS 3 has a high diagnostic performance for detecting recurrence.</p>\",\"PeriodicalId\":7875,\"journal\":{\"name\":\"American Journal of Neuroradiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549942/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Neuroradiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3174/ajnr.A7992\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/9/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Neuroradiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3174/ajnr.A7992","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/14 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:颈部成像报告和数据系统(NI-RADS)是一种用于头部和颈部癌症治疗后随访成像的报告模板。目的:我们的目的是评估基于每个NI-RADS类别的头颈部鳞状细胞癌复发的合并检测率,并比较NI-RADS 2和3个切口的诊断准确性。数据来源:检索MEDLINE、Scopus和EMBASE数据库。研究选择:这项系统综述确定了7项研究,共有694名患者(1233个病变)符合荟萃分析条件。数据分析:对每个NI-RADS类别的合并复发检测率估计值以及以NI-RADS 3或2为分界点的复发诊断准确性进行了荟萃分析。数据综合:NI-RADS 3、NI-RADS 2和NI-RADS 1在每一类原发性病变中的估计复发率分别为74.4%、29.0%和4.2%。NI-RADS 3、NI-RADS 2和NI-RADS 1在每种类型的颈淋巴结中的估计复发率分别为73.3%、14.3%和3.5%。以NI-RADS 3为截止点的复发检测的汇总受试者工作特性曲线下面积分别为0.887和0.983,高于以NI-RADS2为截止点时原发部位和颈部淋巴结的0.869和0.919。局限性:鉴于研究数据的异质性,应谨慎解读结论。结论:这项荟萃分析揭示了每种NI-RADS类别的原发性病变和颈部淋巴结的估计复发率,并表明NI-RADS 3在检测复发方面具有较高的诊断性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Performance of Neck Imaging Reporting and Data System (NI-RADS) for Diagnosis of Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.

Background: The Neck Imaging Reporting and Data System (NI-RADS) is a reporting template used in head and neck cancer posttreatment follow-up imaging.

Purpose: Our aim was to evaluate the pooled detection rates of the recurrence of head and neck squamous cell carcinoma based on each NI-RADS category and to compare the diagnostic accuracy between NI-RADS 2 and 3 cutoffs.

Data sources: The MEDLINE, Scopus, and EMBASE databases were searched.

Study selection: This systematic review identified 7 studies with a total of 694 patients (1233 lesions) that were eligible for the meta-analysis.

Data analysis: The meta-analysis of pooled recurrence detection rate estimates for each NI-RADS category and the diagnostic accuracy of recurrence with NI-RADS 3 or 2 as the cutoff was performed.

Data synthesis: The estimated recurrence rates in each category for primary lesions were 74.4% for NI-RADS 3, 29.0% for NI-RADS 2, and 4.2% for NI-RADS 1. The estimated recurrence rates in each category for cervical lymph nodes were 73.3% for NI-RADS 3, 14.3% for NI-RADS 2, and 3.5% for NI-RADS 1. The area under the curve of the summary receiver operating characteristic for recurrence detection with NI-RADS 3 as the cutoff was 0.887 and 0.983, respectively, higher than 0.869 and 0.919 for the primary sites and cervical lymph nodes, respectively, with NI-RADS 2 as the cutoff.

Limitations: Given the heterogeneity of the data of the studies, the conclusions should be interpreted with caution.

Conclusions: This meta-analysis revealed estimated recurrence rates for each NI-RADS category for primary lesions and cervical lymph nodes and showed that NI-RADS 3 has a high diagnostic performance for detecting recurrence.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.10
自引率
5.70%
发文量
506
审稿时长
2 months
期刊介绍: The mission of AJNR is to further knowledge in all aspects of neuroimaging, head and neck imaging, and spine imaging for neuroradiologists, radiologists, trainees, scientists, and associated professionals through print and/or electronic publication of quality peer-reviewed articles that lead to the highest standards in patient care, research, and education and to promote discussion of these and other issues through its electronic activities.
期刊最新文献
Artificial Intelligence-Generated Editorials in Radiology: Can Expert Editors Detect Them? The many faces of myxopapillary ependynomas. Vestibular schwannoma-related increased labyrinthine post-gadolinium 3D-FLAIR signal intensity and association with hearing impairment. CNS Embryonal Tumor with PLAGL Amplification, a New Tumor Type in Children and Adolescents: Insights from a Comprehensive MRI Analysis. DSA Quantitative Analysis and Predictive Modeling of Obliteration in Cerebral AVM following Stereotactic Radiosurgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1